Injecting functional adenosine deaminase into a patient's (lacking $ADA$ gene) blood cells may be considered as

  • A
    Gene therapy
  • B
    Enzyme replacement therapy
  • C
    Both $(a)$ and $(b)$
  • D
    Genetic engineering

Explore More

Similar Questions

Which of the following statements is $NOT$ correct?

Adenosine deaminase $(ADA)$ deficiency is most commonly caused by which genetic abnormality?

How is gene therapy useful for the treatment of various diseases?

List the advantages of recombinant insulin.

$\alpha-1$ antitrypsin is

Vedclass Products

For Students

Vedclass Test Series

Mock tests in real JEE/NEET style with performance analysis. 5-day free trial.

Start Free Trial
For Teachers

Exam Paper Generator

Generate Set A/B/C/D exam papers from 7.5L+ questions in 2 minutes. 3 chapters free.

Try Free
For Institutes

Online Exam Module

Live online exams with unlimited students, 360° analytics & white-label branding.

See Demo